Abstract

The Problem

Asthma management in the UK remains largely reactive. Current clinical reviews rely on subjective patient self-reporting, which creates an "adherence blind spot" masking SABA over-reliance and poor technique. This can lead to overescalation of ICS and unnecessary escalation to high-cost biologics when the underlying issue is behavioural. Pilot audits also revealed that 9% of patients were unknowingly using empty ICS inhalers, while 8% were using empty SABA inhalers.


The Change

Darshan Negandhi (Senior Clinical Pharmacist & IP) and the clinical research teams at Smart Respiratory and Pearl Chemist Group implemented a digitally-enhanced pharmacy review model within a Neighbourhood Health framework.

The service fosters GP-Pharmacist cooperation: GPs refer high-risk patients to community pharmacists for a two-consultation "blended" review. Pharmacists deploy a digital sensor (Smart Inhaler Assistant) to monitor objective adherence and maintenance inhaler use for 4–8 weeks. Outcomes are reported back to the GP via GP Connect (or similar), contributing directly to the practice's asthma QOF targets.

Measures & Evidence of Change

In a pilot of 47 high-risk patients (77% ICS+SABA, 23% MART+SABA):
Clinical Impact: The Very Poorly Controlled (VPC) cohort achieved a mean ACT improvement of +5.3 points (Significantly exceeding the MCID of +3.0). The Not Well Controlled group gained +3.3 points.

Safety & Triage: 18% of very poorly controlled asthma patients were identified as "refractory" (high adherence and decent technique but poor control) and fast-tracked for specialist referral.

Economic Value: At a service cost of £63/patient, the VPC cohort delivered in-year cashable hospital savings (reduced ED/admissions) of £960/patient, representing a 15.2:1 cashable ROI.

Capacity: Primary care productivity gains were valued at £610/patient (VPC) and £380/patient (NWC) based on reduced unscheduled interactions (OPCRD/Thomas M, et al. 2009).


Final Message

Blended digital pathways in community pharmacy effectively "close the loop" in asthma care. By providing objective data to Integrated Neighbourhood Teams, the service prevents "treatment drift," releases primary care capacity, and delivers a robust ROI by correcting behavioural adherence before hospitalisation occurs.